Valuation Scholar Rock Holding Corporation

Stocks

Market Closed - Nasdaq 04:00:00 2026-10-16 pm EDT			5-day change	1st Jan Change
39.90 ^USD	-1.82%		-5.45%	-9.42%

Oct. 08	Scholar Rock Resubmits Apitegromab Application in EU for Spinal Muscular Atrophy	MT
Oct. 08	Scholar Rock Resubmits Apitegromab Marketing Authorisation Application To European Medicines Agency For Treatment Of Children And Adults With Spinal Muscular Atrophy	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	872.1	467.6	1,356	4,046	4,493	4,949	-	-
Change	-	-46.39%	190.08%	198.32%	11.06%	10.15%	-	-
Enterprise Value (EV) ¹	709.3	414	1,304	3,918	4,270	4,633	4,539	4,559
Change	-	-41.63%	215.07%	200.38%	8.97%	8.51%	-2.03%	0.45%
P/E	-6.92x	-4x	-9.45x	-17.5x	-13.4x	-12.4x	-15.7x	-31.1x
PBR	5.3x	2.07x	6.96x	11x	20.6x	18.7x	16.4x	17.4x
PEG	-	0.1x	0.8x	-0.7x	-0.4x	54.69x	0.7x	0.6x
Capitalization / Revenue	46.3x	14.1x	-	-	-	872x	34.8x	12.6x
EV / Revenue	37.7x	12.5x	-	-	-	816x	31.9x	11.6x
EV / EBITDA	-5.57x	-	-	-	-11.1x	-10.8x	-14.7x	-39.7x
EV / EBIT	-5.46x	-3.08x	-7.62x	-15.5x	-11.1x	-10.6x	-13.1x	-28.4x
EV / FCF	-5.37x	-3.1x	-8.98x	-19.5x	-14.2x	-16.7x	-20.7x	-54.1x
FCF Yield	-18.6%	-32.3%	-11.1%	-5.13%	-7.04%	-5.98%	-4.83%	-1.85%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-3.59	-2.26	-1.99	-2.47	-3.29	-3.283	-2.584	-1.308
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	18.82	33.19	-	-	-	5.677	142.2	393.7
EBITDA ¹	-127.3	-	-	-	-383	-429.2	-308.8	-114.9
EBIT ¹	-129.9	-134.4	-171.3	-252.1	-384.6	-437.1	-345.3	-160.8
Net income ¹	-131.8	-134.5	-165.8	-246.3	-377.9	-429.8	-359.7	-178.7
Net Debt ¹	-162.8	-53.53	-51.84	-127.7	-223.8	-316.5	-410.4	-390
Reference price ²	24.84	9.05	18.80	43.22	44.05	40.64	40.64	40.64
Nbr of stocks (in thousands)	35,108	51,663	72,143	93,615	102,007	121,785	-	-
Announcement Date	3/7/22	3/7/23	3/19/24	2/27/25	3/3/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
SCHOLAR ROCK HOLDING CORPORATION	-12.38x	816.02x	-10.8x	-.--%	4.95B
WUXI APPTEC CO., LTD.	20.07x	7.14x	14.31x	1.48%	68.98B
ARGENX SE	28.61x	7.85x	24.63x	0.05%	53.15B
LONZA GROUP AG	35.29x	6.26x	18.73x	0.92%	50.83B
IQVIA HOLDINGS INC.	34.21x	3.36x	14.49x	-.--%	44.61B
REVOLUTION MEDICINES, INC.	-19.62x	197.94x	-20.83x	-.--%	40.57B
BEONE MEDICINES AG	49.56x	5.68x	31.19x	-.--%	42.53B
CELLTRION, INC.	27.19x	7.72x	19.99x	0.39%	30.95B
WUXI BIOLOGICS (CAYMAN) INC.	29.37x	6.23x	16.17x	-.--%	25.44B
BIONTECH SE	-13.66x	5.14x	-6.23x	-.--%	22.66B
Average	17.86x	106.33x	10.17x	0.28%	38.47B
Weighted average by Cap.	22.76x	36.92x	13.55x	0.42%